Ocular Therapeutix (NASDAQ:OCUL) Stock Rating Reaffirmed by Piper Sandler
Ocular Therapeutix (NASDAQ:OCUL – Get Free Report)‘s stock had its “overweight” rating reiterated by research analysts at Piper Sandler in a note issued to investors on Friday, Benzinga reports. They presently have a $15.00 target price on the biopharmaceutical company’s stock. Piper Sandler’s target price would suggest a potential upside of 145.50% from the stock’s […]
More Stories
As Battle Group Off Venezuela Awaits Orders, a New Commander Takes the Helm
By John Haughey DORAL, Fla.—The largest United States naval force to prowl the Caribbean in decades is steaming off Venezuela’s...
2 US Army Soldiers, Civilian Interpreter Killed by ISIS Gunman in Syria
By Tom Ozimek Two U.S. Army soldiers and a civilian interpreter were killed, and three others were injured in an...
ICE Announces Arrest of 400 Illegal Immigrants in Minnesota
By Naveen Athrappully More than 400 illegal immigrants have been arrested in Minnesota by Immigration and Customs Enforcement (ICE) as...
Underlying Factors in Minnesota Welfare Fraud: Readers Weigh In
By Lawrence Wilson Minnesota is now the center of a major pandemic-era welfare-fraud investigation that has outraged taxpayers nationwide. Much...
With More Nations Than Ever, World Cup 2026 Brings a Security Challenge
By Chris Summers The 2026 World Cup soccer tournament will present a major security challenge for its main host, the...
DOJ Sues Georgia’s Fulton County for Access to 2020 Ballots
By Stacy Robinson The Department of Justice (DOJ) is suing Fulton County, Georgia, to obtain voting records from the 2020...